Discover 1,436 paid clinical trials in Renton, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,436
Active & Responsive
Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
for
Solid Tumor, Adult, Colorectal Cancer,
Location: Seattle WA, Palo Alto CA, Santa Monica CA, La Jolla CA,
Sponsor: A2 Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT04981119
Recruiting
Active & Responsive
A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
for
Solid Tumor, Adult, Colorectal Cancer, NSCLC,
Location: Seattle WA, Stanford CA, Los Angeles CA, La Jolla CA,
Sponsor: A2 Biotherapeutics Inc.
Sex: All
Age: 18+
Code: NCT06051695
Phase1, Phase2, Recruiting
Active & Responsive
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
for
HER2-positive Metastatic Breast Cancer
Location: Seattle WA, San Francisco CA, New Lenox IL,
Sponsor: Abramson Cancer Center at Penn Medicine
Sex: All
Age: 18+
Code: NCT06551116
Recruiting
Active & Responsive
Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
for
Acute Myeloid Leukemia, Myelodysplastic Syndromes
Location: Seattle WA, St Louis MO, Pittsburgh PA
Sponsor: Sawa Ito, MD
Sex: All
Age: 18+
Code: NCT06529731
Phase2, Recruiting
Active & Responsive
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
for
Localized Renal Pelvis and Ureter Urothelial Carcinoma,
Location: Seattle WA
Sponsor: University of Washington
Sex: Male
Age: 18+
Code: NCT01050504
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies
for
Lymphoma, B-Cell, Lymphoma, Non-Hodgkin (NHL),
Location: Seattle WA, Omaha NE, St Louis MO, Chicago IL,
Sponsor: Umoja Biopharma
Sex: All
Age: 18+
Code: NCT06528301
Phase1, Recruiting
Active & Responsive
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
Location: Seattle WA, Duarte CA, Minneapolis MN, New York NY,
Sponsor: Tr1X, Inc.
Sex: All
Age: 18+
Code: NCT06462365
Phase1, Recruiting
Active & Responsive
A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT07078604
Phase2, Recruiting
Active & Responsive
[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT06502691
Phase1, Phase2, Recruiting
Active & Responsive
IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence
for
Fallopian Tube Carcinoma, Ovarian Carcinoma,
Location: Seattle WA
Sponsor: University of Washington
Sex: Female
Age: 18+
Code: NCT07495124
Phase2, Recruiting
Active & Responsive
A Vaccine (STEMVAC) With Standard Endocrine-Based Therapy or Chemotherapy for the Treatment of Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer
for
Anatomic Stage IV Breast Cancer AJCC v8,
Location: Seattle WA
Sponsor: University of Washington
Sex: All
Age: 18+
Code: NCT07112053
Phase2, Recruiting
Active & Responsive
FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia
for
Recurrent Childhood Acute Myeloid Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center
Sex: All
Age: 0 - 6
Code: NCT06609928
Phase1, Recruiting
Active & Responsive
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)